Evidence map›Paper›PMID 37556087›Full record

ArticleGeroScience2023

Correction to: Microglial MHC‑I induction with aging and Alzheimer's is conserved in mouse models and humans.

Collyn M Kellogg, Kevin Pham, Adeline H Machalinski, Hunter L Porter, Harris E Blankenship, Kyla B Tooley, Michael B Stout, Heather C Rice, Amanda L Sharpe, Michael J Beckstead and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in GeroScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Collyn M KelloggGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Kevin PhamGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Adeline H MachalinskiGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Hunter L PorterGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Harris E BlankenshipDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Kyla B TooleyGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Michael B StoutAging and Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Heather C RiceDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Amanda L SharpeDepartment of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Michael J BecksteadGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Ana J Chucair-ElliottGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Sarah R OcañasGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA.
Willard M FreemanGenes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13Th Street, Oklahoma City, OK, USA. bill-freeman@omrf.org.

Funding

Targeted DNA Methylation and Mitochondrial Heteroplasmy CoreP30AG050911 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michael T Kinter · 2015 to 2026
$13.9M
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMAT32AG052363 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Benjamin Francis Miller, William Edmund Sonntag · 2017 to 2026
$3.6M
Sex divergence and cell specificity of age-related hippocampal DNA modificationsR01AG059430 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FREEMAN, WILLARD M · 2019 to 2023
$2.7M
Research Supplements to Promote Diversity in Health-Related Research Mechanisms of APP ectodomain functionR35GM142726 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RICE, HEATHER C. · 2021 to 2025
$2.0M
Ventral tegmental area involvement in Alzheimer's pathologyR21AG072811 · NIA · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI BECKSTEAD, MICHAEL J · 2021 to 2021
$481k
Multimodal ventral tegmental area decrements in a mouse Alzheimer's modelF31AG079620 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BLANKENSHIP, HARRIS · 2022 to 2024
$110k
Epigenetic regulation of sexually divergent neuroinflammation with brain aging and Alzheimer's diseaseF31AG064861 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI OCANAS, SARAH RENEE · 2019 to 2021
$94k
BLRD VA I01 BX005396BLRD VA I01 BX005592BLRD VA IK6 BX006033NIA NIH HHS F31 AG064861NIA NIH HHS F31 AG079620NIA NIH HHS P30 AG050911NIA NIH HHS R01 AG059430NIA NIH HHS R21 AG072811NIA NIH HHS T32 AG052363NIGMS NIH HHS R35 GM142726
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37556087
PMCPMC10643469

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.